ENZYMATIC BASIS OF THE DEBRISOQUINE SPARTEINE-TYPE GENETIC-POLYMORPHISM OF DRUG OXIDATION - CHARACTERIZATION OF BUFURALOL 1'-HYDROXYLATION IN LIVER-MICROSOMES OF INVIVO PHENOTYPED CARRIERS OF THE GENETIC DEFICIENCY

被引:69
作者
DAYER, P [1 ]
KRONBACH, T [1 ]
EICHELBAUM, M [1 ]
MEYER, UA [1 ]
机构
[1] UNIV BASEL,BIOCTR,DEPT PHARMACOL,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND
关键词
D O I
10.1016/0006-2952(87)90573-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:4145 / 4152
页数:8
相关论文
共 59 条
[51]   POLYMORPHIC DEXTROMETHORPHAN METABOLISM - CO-SEGREGATION OF OXIDATIVE O-DEMETHYLATION WITH DEBRISOQUIN HYDROXYLATION [J].
SCHMID, B ;
BIRCHER, J ;
PREISIG, R ;
KUPFER, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :618-624
[52]   PHARMACOGENETICS OF TOLBUTAMIDE METABOLISM IN HUMANS [J].
SCOTT, J ;
POFFENBARGER, PL .
DIABETES, 1979, 28 (01) :41-51
[53]   IMPAIRED OXIDATION OF DEBRISOQUINE IN PATIENTS WITH PERHEXILINE NEUROPATHY [J].
SHAH, RR ;
OATES, NS ;
IDLE, JR ;
SMITH, RL ;
LOCKHART, JDF .
BRITISH MEDICAL JOURNAL, 1982, 284 (6312) :295-299
[54]  
SHEINER LB, 1983, ELSFIT VERSION 3 0 P
[55]   POLYMORPHISM OF CARBON OXIDATION OF DRUGS AND CLINICAL IMPLICATIONS [J].
SLOAN, TP ;
MAHGOUB, A ;
LANCASTER, R ;
IDLE, JR ;
SMITH, RL .
BRITISH MEDICAL JOURNAL, 1978, 2 (6138) :655-657
[56]  
Snedecor G.w, 1980, STATISTICAL METHODS, P1
[57]   INHIBITION OF DESMETHYLIMIPRAMINE 2-HYDROXYLATION BY DRUGS IN HUMAN-LIVER MICROSOMES [J].
VONBAHR, C ;
SPINA, E ;
BIRGERSSON, C ;
ERICSSON, O ;
GORANSSON, M ;
HENTHORN, T ;
SJOQVIST, F .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2501-2505
[58]   CO-INHERITANCE OF THE POLYMORPHIC METABOLISM OF ENCAINIDE AND DEBRISOQUIN [J].
WOOSLEY, RL ;
RODEN, DM ;
DAI, G ;
WANG, T ;
ALTENBERN, D ;
OATES, J ;
WILKINSON, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (03) :282-287
[59]   PHARMACOKINETICS OF N-PROPYLAJMALINE IN RELATION TO POLYMORPHIC SPARTEINE OXIDATION [J].
ZEKORN, C ;
ACHTERT, G ;
HAUSLEITER, HJ ;
MOON, CH ;
EICHELBAUM, M .
KLINISCHE WOCHENSCHRIFT, 1985, 63 (22) :1180-1186